Reduction of Hepatic Steatosis, Oxidative Stress, Inflammation, Ballooning and Insulin Resistance After Therapy with Safranal in NAFLD Animal Model: A New Approach.
Usman SabirHafiz Muhammad Irfannull AlamgeerAman UllahYusuf S AlthobaitiMulazim Hussain AsimPublished in: Journal of inflammation research (2022)
Findings of blood and tissue analysis concluded that safranal can be a good choice in the management and cure of NAFLD.